Abstract: An antibody or antigen-binding antibody fragment having a heavy chain variable region and/or a light chain variable region that specifically binds to Ror2 antigen, as well as immunoconjugates containing the heavy chain variable region and/or the light chain variable region that bind to Ror2 antigen, are provided. Pharmaceutical compositions and kits comprising the polypeptide or antibodies and antibody fragments containing the polypeptide are also provided.
Type:
Grant
Filed:
August 29, 2023
Date of Patent:
May 27, 2025
Assignee:
BioAlta, Inc.
Inventors:
Jay M. Short, Hwai Wen Chang, Gerhard Frey